Navigation Links
Misonix, Inc. Announces First Quarter Fiscal Year 2014 Financial Results
Date:11/7/2013

and lower stocking sales to international markets as compared to the same quarter in fiscal 2013.

BoneScalpel revenue was $1.3 million, SonaStar revenue was $1.1 million and SonicOne® revenue was $469,000 for the first quarter 2014. 

There were 36 BoneScalpel units sold or placed during the first quarter fiscal 2014 compared to 57 BoneScalpel units sold or placed during the first quarter of fiscal 2013.  BoneScalpel domestic disposable sales increased 74% during the first quarter fiscal 2014 compared to the same period in fiscal 2013, excluding Aesculap.

The Company reported a net loss of $884,002, or ($.12) diluted loss per share, compared to net income of $44,834, or $0.01 earnings per share, in fiscal 2013. 

Michael A. McManus, Jr., President and CEO, stated, "This was another quarter for progress for your Company.  You will remember our strategy of consigning units in conjunction with purchases of our disposable blade.  The result of this formula shows continued high margins and an increase of BoneScalpel units in the U.S.  BoneScalpel revenue from disposables increased 74% in the U.S., excluding Aesculap, resulting from an increase of 65% in disposable units from the first quarter of fiscal 2013.  Total recurring revenue from disposables increased to 53% of total sales for the quarter.  These results are all indicators of growth and surgeons continued acceptance and use of our unique technology.  The acceptance of the significant benefits to doctor, patient and hospital are consistently increasing.  We expect to see growth across all products and in all markets over the coming quarter." 

"We are excited about the reception we are receiving at prominent trade shows and professional conferences.  We are experiencing considerable traffic from both surgeons and potential new distributors.  Testimony from prominent surgeons at
'/>"/>

SOURCE Misonix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Misonix, Inc. Announces the Grant of Patent by the United States Patent and Trademark Office
2. Misonix, Inc. Announces Fourth Quarter and Fiscal Year 2013 Financial Results
3. Misonix, Inc. To Report Financial Results For The First Quarter Of Fiscal Year 2014 On Thursday, November 7, 2013
4. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
5. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
6. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
7. Misonix Announces New Distribution Agreement For Panama
8. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
9. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
10. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
11. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... BRIDGEWATER, N.J. , May 5, 2015  CorMedix ... developing and commercializing therapeutic products for the treatment of ... 2015 financial results on May 7.  Randy Milby ... investor conference call on Friday, May 8 at 9:00 ... in the conference call, please call 1-877-407-8031 (U.S.), 1-201-689-8031 ...
(Date:5/5/2015)... 5, 2015   InspireMD, Inc. (NYSE MKT: NSPR) ... announced today that it will release its full financial results ... May 11 th before the open, followed by a ... results and business outlook. Participants should call (888) ... (International) and request the InspireMD call. A live webcast of ...
(Date:5/5/2015)... May 5, 2015 GW Pharmaceuticals plc ... a biopharmaceutical company focused on discovering, developing and ... platform, announced today the closing of the previously ... GW of 1,600,000 American Depositary Shares (ADSs) at ... proceeds of approximately $179.2 million (before deducting underwriting ...
Breaking Medicine Technology:CorMedix, Inc. to Report First Quarter Financial Results on May 8, 2015 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4
... Oct. 1 VirtualScopics, Inc. (Nasdaq: VSCP ), ... revenues for the third quarter ended September 30, 2010 exceeded ... comparable period in 2009 and a greater than 9% growth ... increased over 30% for the period ended September 30, 2010 ...
... 1 Palatin Technologies, Inc. (NYSE Amex: PTN ... Annual BIO Investor Forum on Wednesday, October 6, 2010 at ... the 9th Annual BIO Investor Forum will take place October ... Carl Spana, Ph.D., President and Chief Executive Officer ...
Cached Medicine Technology:VirtualScopics Revenues Hit Another Quarterly Record 2VirtualScopics Revenues Hit Another Quarterly Record 3
(Date:5/6/2015)... May 06, 2015 More and more people ... created by Brian Flatt, personal trainer and nutritionist. This particular ... 23 pounds in just three weeks or 21 days. , ... been scientifically tested and found to work on all types ... On average, people lose between 12 and 23 pounds using ...
(Date:5/5/2015)... VA (PRWEB) May 06, 2015 Social ... Regulations, Make Social Media Your Most Powerful Marketing Tool ... – Washington, DC, http://www.fdanews.com/SocialMedia , Social media ... dream of social media’s reach. Patients are using it ... their doctors about what they’ve discovered. , But, it ...
(Date:5/5/2015)... 2015 The Journal of ... “ Priority interventions to improve the management of ... research of the ACCORD program ” , As ... actors, including clinicians, patients and family members, managers, ... which included knowledge gap, “work in silos”, lack ...
(Date:5/5/2015)... FL (PRWEB) May 05, 2015 ... company focused on the $1.6 billion peripheral nerve repair ... first quarter ended March 31, 2015 compared to $3.14 ... market’s continued adoption of our proprietary portfolio of nerve ... Connector and AxoGuard® Nerve Protector – and our solid ...
(Date:5/5/2015)... May 05, 2015 The 2015 Crystal Ball, ... to benefit their global research, outreach and patient advocacy programs. ... and awards ceremony that attracted hundreds of supporters. , The ... discovery of the hepatitis B virus (HBV) by Dr. Baruch ... the Nobel Prize in Medicine for his discovery of the ...
Breaking Medicine News(10 mins):Health News:Brian Flatt Announces The 3 Week Diet - A Scientifically Proven Diet Plan 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 3Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 4Health News:Priority interventions in chronic non-cancer pain published by Dove Medical Press 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3
... More than 600 people will gather for the Consortium ... held at the University of Washington in Seattle on ... in global health. The conference is the largest university-based ... all of the major university-based global health programs in ...
... journal Nature , Miguel Godinho Ferreira, Principal Investigator ... lead a team of researchers to shed light on ... of telomeres, the protective tips of chromosomes: while broken ... or cigarette smoke) are quickly joined together, telomeres are ...
... commonly prescribed to treat adolescent acne can increase attention ... fragile X syndrome, the most common inherited cause of ... is the first published on parents, reports of their ... by researchers at the UC Davis MIND Institute, the ...
... By Ellin Holohan HealthDay Reporter , WEDNESDAY, Sept. ... notion that angioplasty, a common procedure to open clogged arteries, ... a new study shows. In fact, the evidence suggests ... heart patients -- people whose condition has not changed recently ...
... fabrics to keep clothing looking fresh and wrinkle-free is unlikely ... article in the current issue of Chemical & Engineering News ... J. Hanson notes that manufacturers have added formaldehyde to fabrics ... care for, particularly to reduce wrinkling in cotton and prevent ...
... team representing the schools of Medicine, Nursing and Social ... clinical pastoral education programs in three Louisville hospitals, has ... Institutes of Health that will fund the development, implementation ... program. Work related to the project will begin immediately. ...
Cached Medicine News:Health News:University, government and philanthropic leaders converge in Seattle to advance global health 2Health News:University, government and philanthropic leaders converge in Seattle to advance global health 3Health News:Why chromosomes never tie their shoelaces 2Health News:Why chromosomes never tie their shoelaces 3Health News:Parents report a widely prescribed antibiotic is effective for fragile X treatment 2Health News:Parents report a widely prescribed antibiotic is effective for fragile X treatment 3Health News:Parents report a widely prescribed antibiotic is effective for fragile X treatment 4Health News:Many Heart Patients Place False Hope in Angioplasty 2Health News:Many Heart Patients Place False Hope in Angioplasty 3Health News:Grant will aid creation of interdisciplinary oncology palliative care education program 2Health News:Grant will aid creation of interdisciplinary oncology palliative care education program 3
Inquire...
Inquire...
... Tura, the new Lulu Guinness Eyewear line ... retro Lulu Guinness herself. This collection brings ... the past with a flair for contemporary ... flair include a sizable collection of prescription ...
... a variety of colors and classic ... styles designed with elegant jewel detail. ... women that are made from the ... in our fine timepieces, Timex branded ...
Medicine Products: